Mallinckrodt Announces Publication of Findings on Treatment Patterns and Outcomes in Patients with Two Types of Arthritis Treated with Acthar® Gel (repository corticotropin injection)

– Cross-sectional physician survey and medical chart review showed some patients evaluated with AS or PsA who were treated with Acthar Gel experienced a reported reduction in overall symptoms, decreased pain, improved physical function, reduced corticosteroid use, improved strength, and...